Serum and tissue markers of myopathy in patients with colorectal cancer
Skeletal muscles in patients with cancer undergo many changes due to immuno-inflammatory factors of tumor origin, or to chemotherapy and irradiation. Aim of the present study is to identify serological biomarkers and early myopathic features in skeletal muscle biopsies from weight stable patients be...
Saved in:
Main Author: | Nicoletta Adami (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2012-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Subclinical myopathy in patients with colorectal cancer: clinical-pathological characterization and search for tissue markers
by: Massimo Vecchiato, et al.
Published: (2012) -
Risk of Myopathy in Patients in Therapy with Statins: Identification of Biological Markers in a Pilot Study
by: Giulia M. Camerino, et al.
Published: (2017) -
Colorectal cancer genomic biomarkers in the clinical management of patients with metastatic colorectal carcinoma
by: Anna Maria Rachiglio, et al.
Published: (2020) -
Clinical Significance of Abnormal Serum LGALS3BP Expression in Patients with Idiopathic Inflammatory Myopathies
by: Huang L, et al.
Published: (2024) -
Bethlem Myopathy
by: J Gordon Millichap
Published: (1999)